Caries Transmission Prevention in Alaska Native Infants
NCT ID: NCT00067340
Last Updated: 2015-06-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE3
250 participants
INTERVENTIONAL
2003-04-30
2006-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study on Use of Xylitol-wipes to Prevent Dental Caries
NCT01468727
Evaluation of Oral Hygiene Products in an In Situ Caries Model
NCT02399163
Is Xylitol Toothpaste Effective in Preventing Tooth Decay?
NCT04096599
Evaluating the Effect of Xylitol Wipes on Cariogenic Bacteria in Infants and Toddlers
NCT07245433
Comparing Mouth Rinses (and Chewing Gum) in Regard to Streptococcus Mutans Reduction
NCT02598778
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The specific aim of this proposal is to conduct a community based, randomized blinded trial to determine if the serial use of chlorhexidine and xylitol will reduce the vertical transmission of caries between Alaska Native mothers and infants. We hypothesize that a two week period of twice-daily chlorhexidine mouthwash use prior to delivery, followed by a subsequent two year period of maternal xylitol gum use, will lead to a significant reduction in the age-specific prevalence of early childhood caries at 12 and 24 months of age among the offspring of mothers in the intervention group, compared to control group mothers. We also hypothesize that, compared to controls, mothers and children in the intervention group will have significant reductions in oral MS counts at each follow-up interval.
If proven successful, this intervention could have a significant impact on the prevalence of caries among young Alaska Native children and other population groups at high risk for childhood caries.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group
Subjects received chlorhexidine mouthwash and xylitol gum , in addition to the usual care specified under the control group
Chlorhexidine mouth rinse
women received daily chlorhexidine oral rinses for two weeks prior to delivery of the infant.
Xylitol chewing gum
Women were asked to chew xylitol chewing gum three times per day following the birth of their infant for up to two years postpartum
Control
Subjects received enhanced dental care, health information, toothbrushes and toothpaste. They also received placebo gum and placebo mouth rinse
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Chlorhexidine mouth rinse
women received daily chlorhexidine oral rinses for two weeks prior to delivery of the infant.
Xylitol chewing gum
Women were asked to chew xylitol chewing gum three times per day following the birth of their infant for up to two years postpartum
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Dental and Craniofacial Research (NIDCR)
NIH
University of Washington
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
David Grossman
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David Grossman, MD MPH
Role: PRINCIPAL_INVESTIGATOR
University of Washington
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Washington
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
19945-C
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.